David M. Donovan
19Patents
6h-index
23Co-inventors
66Inventor score
Filing activity: Jan 15, 1981 → Apr 4, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7572602B1 | Nucleic acid encoding endolysin fusion protein | Chemistry; Metallurgy | 16 | Expired |
| US9068204B2 | Peptidoglycan hydrolase antimicrobials for eradicating lactobacilli that contaminate and reduce ethanol yields in biofuel fermentation | Emerging Cross-Sectional Technologies | 8 | Active |
| US8383102B2 | Fusion of peptidoglycan hydrolase enzymes to a protein transduction domain allows eradication of both extracellular and intracellular gram positive pathogens | Chemistry; Metallurgy | 8 | Active |
| US8568714B2 | Lys K endolysin is synergistic with lysostaphin against MRSA | Chemistry; Metallurgy | 7 | Active |
| US8481289B2 | Triple acting antimicrobials that are refractory to resistance development | Chemistry; Metallurgy | 7 | Active |
| US4348136A | Spill oil containment system | Emerging Cross-Sectional Technologies | 6 | Expired |
| US8962297B2 | Bacteriophage lytic enzymes as alternative antimicrobials | Chemistry; Metallurgy | 2 | Active |
| US8361772B2 | Specific lysis of staphylococcal pathogens by bacteriophage phi11 endolysin | Human Necessities | 1 | Active |
| US7982003B2 | Creating designer antimicrobials; peptidoglycan hydrolase module shuffling | Chemistry; Metallurgy | 1 | Active |
| US11236315B2 | Thermophile peptidoglycan hydrolase fusion proteins and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US8012730B1 | Specific lysis of staphylococcal pathogens by bacteriophage phi11 endolysin | Human Necessities | 1 | Active |
| US8790639B2 | Enhanced antimicrobial lytic activity of a chimeric Ply187 endolysin | Chemistry; Metallurgy | 1 | Active |
| US9868943B2 | Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB—SauS-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions, deletions and synergy with LysH5 | Chemistry; Metallurgy | 0 | Active |
| US9545431B1 | Isolated recombinant cDNA | Chemistry; Metallurgy | 0 | Active |
| US10544406B2 | Characterization of four prophage endolysins specific for clostridium perfringens | Chemistry; Metallurgy | 0 | Active |
| US9206411B2 | Staphylococcal Phage2638A endolysin amidase domain is lytic for Staphylococcus aureus | Chemistry; Metallurgy | 0 | Active |
| US8986695B2 | Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB—SauS-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions, deletions and synergy with LysH5 | Chemistry; Metallurgy | 0 | Active |
| US8980614B2 | Staphylococcus haemolyticus prophage φSH2 endolysin is lytic for Staphylococcus aureus | Chemistry; Metallurgy | 0 | Active |
| US9567575B2 | Phage twort endolysin CHAP domain is lytic for Staphylococcus aureus | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.